Search…

    Saved Articles

    You have not yet added any article to your bookmarks.

    Browse

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

    5 hours ago

    The pharma giant will pay $1.2 billion up-front for efimosfermin, with the deal including potential success-based milestone payments of $800 million.
    Click here to Read more
    Prev Article
    Cannes 2025 Opening Ceremony: Robert De Niro awarded honorary Palme d'Or
    Next Article
    Türkiye Kupası'nda dev randevu!

    Related Health Updates:

    Comments (0)

      Leave a Comment